MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug
MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug ...
TipRanks on MSN2d
MAIA Biotechnology publishes preclinical data for telomere-targeting THIO dimer
MAIA Biotechnology (MAIA) announced the publication of preclinical data for its lead proprietary telomere-targeting THIO dimer in the ...
Investing2d
MAIA Biotechnology reports breakthrough in cancer treatment research
The study focused on the THIO dimer’s ability to inhibit Glutathione S-transferase Pi (GSTP1), an enzyme that plays a significant role in cancer progression and resistance to chemotherapy.
Business Wire2d
MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug
In a preclinical study, THIO and its new described dimer form were found to be potent inhibitors of Glutathione S-transferase Pi (GSTP1), a key enzyme implicated in cancer progression and ...